Global

CN EN
  1. HOME
  2. ABOUT US
    About Laekna Core Management Team Board of Directors Milestones Scientific Advisory Board Core Investors Honors & Awards
  3. R&D
    R&D Therapeutic Areas Candidates Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development Holistic Approach BD Contact
  5. INVESTORS
    Corporate Governance Financial Results Announcements and Circulars IR Calendar Listing Documents
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Global Team Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
NEWS
PRESS CENTER

Scroll down to see more

Latest Articles
Media Coverage Press Releases
Search
  1. 2024-07-02
    Investigator Meeting of Laekna AFFIRM-205(a phase III clinical study of breast cancer) Held in Beijing
    Investigator Meeting of Laekna AFFIRM-205(a phase III clinical study of breast cancer) Held in Beijing
    More
    More
    More
  2. 2024-06-28
    Laekna Donated a Children’s Innovation Science Classroom to a School in Gansu Province
    More
  3. 2024-06-26
    Laekna Announces First Subject Dosed in Phase I Clinical Trial of LAE102 (a monoclonal antibody against ActRIIA) in China for The Treatment of Obesity
    More
  4. 2024-05-30
    Laekna Announces First Patient Enrolled in AFFIRM-205, a Phase III Clinical Study of LAE002 (afuresertib) Plus Fulvestrant for Treatment of Breast Cancer
    More
  5. 2024-05-23
    Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer
    More
  6. 2024-05-13
    Laekna in Process to Complete the Regulatory Requirements to Commence Enrollment of Patients for Phase I Clinical Trial of LAE102 for Treatment of Obesity
    More
  7. 2024-04-29
    Laekna Releases 2023 ESG Report
    More
123459
Media contact
communication@laekna.com
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. NEWS
  7. CAREERS
  8. CONTACT US

Copyright © Laekna Therapeutics, All Rights Reserved.  沪ICP备17047795号 Privacy Policy

Follow us on Linkedin

Follow us on Wechat